Kawasaki Disease (Mucocutaneous Lymph Node Syndrome)
Clinical Practice Guidelines : Kawasaki disease
Know your Kawasaki Disease Symptoms · Kawasaki Disease Canada
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease | Pediatric Annals
Kawasaki disease: AHA statement and recommendations
RAISE Study: New evidence of Kawasaki disease's treatment
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease | Circulation
Recommended clinical guideline for the management of Kawasaki disease... | Download Scientific Diagram
Treatment of Kawasaki disease | Download Table
Management of Kawasaki disease | Archives of Disease in Childhood
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial - The Lancet Child & Adolescent Health
Diagnosis and Management of Kawasaki Disease | AAFP
Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease - ScienceDirect
Frontiers | Kawasaki Disease
The contemporary treatment challenges in acute Kawasaki disease
Kawasaki Disease Symptoms | Kawasaki Kids Foundation
Diagnosis and Management of Kawasaki Disease | AAFP
Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks | Italian Journal of Pediatrics | Full Text
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
